Joanne Marjason

546 total citations
17 papers, 418 citations indexed

About

Joanne Marjason is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joanne Marjason has authored 17 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 4 papers in Infectious Diseases and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joanne Marjason's work include Mosquito-borne diseases and control (6 papers), Viral Infections and Vectors (4 papers) and Malaria Research and Control (4 papers). Joanne Marjason is often cited by papers focused on Mosquito-borne diseases and control (6 papers), Viral Infections and Vectors (4 papers) and Malaria Research and Control (4 papers). Joanne Marjason collaborates with scholars based in Australia, United States and France. Joanne Marjason's co-authors include Joseph Proietto, James E. Vath, Thomas E. Hughes, D. J. Byrnes, Jasper Dingemanse, Jonathan P. Whitehead, Suzanne Elliott, Shirin Bruderer, Patricia N. Sidharta and Elissa Malkin and has published in prestigious journals such as Gastroenterology, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Joanne Marjason

17 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne Marjason Australia 12 138 79 72 69 59 17 418
Eduardo Montoya-Díaz Mexico 10 143 1.0× 72 0.9× 66 0.9× 142 2.1× 60 1.0× 13 370
Anja Schmidt-Christensen Sweden 12 178 1.3× 81 1.0× 16 0.2× 133 1.9× 98 1.7× 24 494
Meng-Ti Hsieh Taiwan 9 184 1.3× 116 1.5× 147 2.0× 42 0.6× 57 1.0× 9 453
Diana Moreira Portugal 11 216 1.6× 136 1.7× 42 0.6× 160 2.3× 266 4.5× 20 597
Rita Káposzta Hungary 11 94 0.7× 127 1.6× 177 2.5× 211 3.1× 166 2.8× 19 584
Miao Jiang China 14 44 0.3× 178 2.3× 140 1.9× 121 1.8× 68 1.2× 35 465
Laura Visconti Italy 9 41 0.3× 176 2.2× 40 0.6× 99 1.4× 110 1.9× 10 462
Reza Jafari-Shakib Iran 12 71 0.5× 64 0.8× 47 0.7× 67 1.0× 141 2.4× 33 383
Graciela Dran Argentina 15 38 0.3× 111 1.4× 74 1.0× 224 3.2× 48 0.8× 32 599
Rajeev Reddy Pappuru India 17 64 0.5× 209 2.6× 60 0.8× 37 0.5× 58 1.0× 61 833

Countries citing papers authored by Joanne Marjason

Since Specialization
Citations

This map shows the geographic impact of Joanne Marjason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Marjason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Marjason more than expected).

Fields of papers citing papers by Joanne Marjason

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Marjason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Marjason. The network helps show where Joanne Marjason may publish in the future.

Co-authorship network of co-authors of Joanne Marjason

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Marjason. A scholar is included among the top collaborators of Joanne Marjason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Marjason. Joanne Marjason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Torresi, Joseph, Peter Richmond, Leon Heron, et al.. (2017). Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding. The Journal of Infectious Diseases. 216(7). 834–841. 20 indexed citations
2.
Torresi, Joseph, Leon Heron, Ming Qiao, et al.. (2015). Lot-to-lot consistency of a tetravalent dengue vaccine in healthy adults in Australia: A randomised study. Vaccine. 33(39). 5127–5134. 19 indexed citations
3.
Krishnarajah, Janakan, Stephen Lillioja, Joanne Marjason, et al.. (2015). Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial. Diabetes Obesity and Metabolism. 17(6). 566–572. 50 indexed citations
4.
Zandvliet, Anthe S., Ann D. Horowitz, Diana Montgomery, et al.. (2014). Tildrakizumab, a novel anti-IL-23 monoclonal antibody, is unaffected by ethnic variability in Caucasian, Chinese, and Japanese subjects. International Journal of Clinical Pharmacology and Therapeutics. 53(2). 139–146. 20 indexed citations
5.
Bruderer, Shirin, Joanne Marjason, Patricia N. Sidharta, & Jasper Dingemanse. (2013). Pharmacokinetics of Macitentan in Caucasian and Japanese Subjects: The Influence of Ethnicity and Sex. Pharmacology. 91(5-6). 331–338. 31 indexed citations
6.
Hughes, Thomas E., et al.. (2013). Ascending dose‐controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women. Obesity. 21(9). 1782–1788. 51 indexed citations
7.
Hoch, Matthias, Petra Hoever, Federica Alessi, Joanne Marjason, & Jasper Dingemanse. (2011). Pharmacokinetics and Tolerability of Almorexant in Japanese and Caucasian Healthy Male Subjects. Pharmacology. 88(3-4). 121–126. 6 indexed citations
8.
McCarthy, James, Joanne Marjason, Suzanne Elliott, et al.. (2011). A Phase 1 Trial of MSP2-C1, a Blood-Stage Malaria Vaccine Containing 2 Isoforms of MSP2 Formulated with Montanide® ISA 720. PLoS ONE. 6(9). e24413–e24413. 70 indexed citations
9.
Brown, Gregor J., A. James M. Daveson, Joanne Marjason, et al.. (2011). A Phase I Study to Determine Safety, Tolerability and Bioactivity of Nexvax2® in HLA DQ2+ Volunteers With Celiac Disease Following a Long-Term, Strict Gluten-Free Diet. Gastroenterology. 140(5). S–437. 25 indexed citations
10.
Pierce, Mark A., Ruth D. Ellis, Elissa Malkin, et al.. (2010). Phase 1 safety and immunogenicity trial of the Plasmodium falciparum blood-stage malaria vaccine AMA1-C1/ISA 720 in Australian adults. Vaccine. 28(10). 2236–2242. 23 indexed citations
12.
Nasveld, Peter, Joanne Marjason, John Aaskov, et al.. (2010). Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine. Human Vaccines. 6(11). 906–914. 29 indexed citations
13.
Marjason, Joanne, Earl St. Rose, Gary T. Ferguson, et al.. (2010). Assessment Of Safety And Pharmacokinetic Profile Of A Novel Fixed Combination Of Glycopyrrolate And Formoterol HFA MDI In Healthy Volunteers. A4455–A4455. 6 indexed citations
14.
Cripps, Allan W., et al.. (2006). Safety and Immunogenicity of an Oral Inactivated Whole-CellPseudomonas aeruginosaVaccine Administered to Healthy Human Subjects. Infection and Immunity. 74(2). 968–974. 42 indexed citations
15.
Byrnes, D. J., et al.. (1979). Release of Secretin—Plasma Levels Reproduced by Exogenous Infusion. Australian and New Zealand Journal of Medicine. 9(2). 151–153. 2 indexed citations
16.
Byrnes, D. J., et al.. (1979). Is Pancreatic Polypeptide Estimation of Value in Diagnosing Gastrinomas (Zollinger‐Ellison Syndrome)?. Australian and New Zealand Journal of Medicine. 9(4). 364–366. 2 indexed citations
17.
Byrnes, D. J. & Joanne Marjason. (1976). Radioimmunoassay of Secretin in Plasma. Hormone and Metabolic Research. 8(5). 361–365. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026